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Type 2 diabetesA B S T R A C T
Aims: We investigated the risk of latent autoimmune diabetes in adults (LADA) and type 2
diabetes in relation to a healthy lifestyle, the proportion of patients attributable to an
unhealthy lifestyle, and the influence of family history of diabetes (FHD) and genetic sus-
ceptibility.
Methods: The population-based study included incident LADA (n = 571), type 2 diabetes
(n = 1962), and matched controls (n = 2217). A healthy lifestyle was defined by
BMI < 25 kg/m2, moderate-to-high physical activity, a healthy diet, no smoking, and mod-
erate alcohol consumption. We estimated odds ratios (OR) with 95% confidence intervals
(CIs) adjusted for age, sex, education, and FHD.
Results: Compared to a poor/moderate lifestyle, a healthy lifestyle was associated with a
reduced risk of LADA (OR 0.51, CI 0.34–0.77) and type 2 diabetes (OR 0.09, CI 0.05–0.15). A
healthy lifestyle conferred a reduced risk irrespective of FHD and high-risk HLA genotypes.
Having a BMI < 25 kg/m2 conferred the largest risk reduction for both LADA (OR 0.54, CI
0.43–0.66) and type 2 diabetes (OR 0.12, CI 0.10–0.15) out of the individual items.
Conclusion: People with a healthy lifestyle, especially a healthy body weight, have a reduced
risk of LADA including those with genetic susceptibility to diabetes.
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Observational studies indicate that adherence to a healthy
lifestyle, including normal body weight [1] physical activity
[2] a healthy diet [3,4] non-smoking [5] and moderate alcohol
consumption [6] may prevent 75–91% of all cases of type 2 dia-
betes [4,7]. In support hereof, randomised clinical trials found
that lifestyle intervention including moderate weight loss and
increased physical activity reduced the risk of type 2 diabetes
by 40–50% in individuals with high risk to develop the disease
[8]. To what extent other forms of diabetes may be prevented
by a healthy lifestyle is, however, unclear.
Latent autoimmune diabetes in adults (LADA) is a hybrid
from of diabetes [9]; similar to type 1 diabetes it is charac-
terised by autoimmune reactivity, HLA-DQB1 genotypes asso-
ciatedwith autoimmunity [10,11] and excess risk conferred by
family history of type 1 diabetes [12]. LADA also shares fea-
tures with type 2 diabetes, including adult onset, insulin
resistance [9,13] and, according to some studies [14,15]
increased frequency of TCF7L2 risk genotypes, which is pri-
marily seen for less autoimmune LADA [16]. Lifestyle factors
linked to type 2 diabetes have been associated with LADA
[17] including overweight [18] physical inactivity [19,20] diet
[21,22] smoking [23] and alcohol consumption [24]. However,
to what extent the combination of healthy lifestyle factors
may reduce the risk of LADA is not clear; to date only one
study, based on few cases and a limited number of lifestyle
factors have addressed this issue [25]. Therefore, our aim
was to investigate the risk of LADA in relation to the combina-
tion of healthy lifestyle factors, and to estimate the propor-
tion of cases attributable to an unhealthy lifestyle. We also
investigated whether a healthy lifestyle may reduce the risk
of LADA in individuals with family history of diabetes (FHD)
or genetic susceptibility as indicated by high-risk genotypes
of HLA or TC7FL2.
2. Subjects, materials and methods
2.1. Study population
Analyses were based on data from a Swedish population-
based case-control study with incident cases of LADA and
type 2 diabetes and matched controls. The ‘‘All New Diabetics
In Scania” (ANDIS) study is an extensive diabetes registry and
biobank aimed to characterise all incident diabetes cases in
Scania county, Sweden [26]. Nested in the ANDIS Study, the
‘‘Epidemiological Study of Risk Factors for LADA and Type 2
Diabetes” (ESTRID) is an ongoing population-based case–con-
trol study established in 2010 (described elsewhere in detail
[21]). In brief, ESTRID recruits all incident cases of LADA and
a random sample of patients with type 2 diabetes from ANDIS
(four cases per LADA case). Since 2012, individuals from the
‘‘All New Diabetics in Uppsala County” (ANDiU) study are
additionally included. Non-diabetic control individuals with
age  35 years are randomly selected from the national pop-
ulation register and matched to the cases through incidence
density sampling (six controls per LADA case) [27]. Analyses
were based on all cases and controls collected September
2010 through October 2019 with complete information on all
exposures and confounders variables (94.1% of sample); 571LADA, 1962 type 2 diabetes, and 2217 controls. Since controls
in ESTRID lack genetic data, we used population-based con-
trols from the ‘‘Epidemiological Investigation of Rheumatoid
Arthritis” (EIRA) study for stratification based on genetic risk
[28]. These controls, hereafter referred to as genetic controls,
were recruited 1996–2014, free of diabetes, had complete
information on lifestyle except for diet, at least one of the
genetic variants of interest, and were matched to the diabetes
cases by sex and birth year (n = 1634). All participants gave
written informed consent and the Regional Ethical Review
Board in Stockholm approved the study.
2.2. Diabetes classification and laboratory analyses
Cases of LADA and type 2 diabetes were diagnosed within the
health care system and blood samples were collected. GADA
was determined using ELISA (RSR, Cardiff, UK); values > 250
U/mL were censored at 250 U/mL, and the cut-off level for
positivity was 10 U/mL (estimated with 84% sensitivity and
98% specificity). Fasting plasma C-peptide was determined
using IMMULITE 2000 (Siemens Healthcare Diagnostics, Llan-
beris, UK) or Cobas e 601 (Roche Diagnostics, Mannheim, Ger-
many). LADA was defined as age  35 at diagnosis, GADA
positivity, and C-peptide levels above the lower limit for the
normal range (0.2 nmol/L (IMMULITE) or  0.3 nmol/L
(Cobas)). Type 2 diabetes was defined as age  35 at diagnosis,
GADA negativity, and C-peptide levels > 0.6 nmol/L (IMMU-
LITE) or  0.72 nmol/L (Cobas). Homeostatic Model Assess-
ment (HOMA) [29] estimated insulin resistance (HOMA-IR)
and beta cell function (HOMA-B) based on fasting plasma glu-
cose and C-peptide levels. This method correlates well with
the hyperinsulinaemic-euglycaemic clamp method [29]. No
clinical information was available for controls.
DNA of the cases was analysed using iPLEX Gold technol-
ogy (Sequenom Laboratories, San Diego, CA, USA). Imputation
of missing genotypes was performed on an subset using Infi-
nium CoreExome v1.1 (Illumina, San Diego, CA, USA) based on
the Haplotype Reference Consortium (http://www.haplotype-
reference-consortium. org/; version r1.1 2016) panel. Genetic
controls were genotyped using GWAS data from Illumina Glo-
bal Screening array or Infinium Illumina 300 K immunochip
custom array (Illumina, USA). We used the single nucleotide
polymorphism (SNP) most strongly associated with type 2
diabetes, TCF7L2 rs7903146, for stratified analysis across the
genetic variants (TT/CT vs. CC). Furthermore, we used tree
SNPs in the HLA complex (rs3104413, rs2854275, rs9273363),
shown to predict high-risk HLA DR/DQ genotypes associated
with autoimmunity, with an overall accuracy of 99.3% [30].
The three SNPs were combined to identify high-risk (DR4-
DQ8, DR4/3-DQ8, DR3/4, DR3/3, DR4/4, DRB1*0301-
DQA1*0501-DQB1*0201) and other HLA genotypes (DR3/X,
DR4/X, DR4-DQ7, DRX/X [31]; X denotes any other allele than
DR3, DR4, or DR7).
2.3. Healthy lifestyle components and covariates
At the time of recruitment, cases and controls answered a
similar, extensive questionnaire on lifestyle habits; cases
received the questionnaire close to time of diagnosis (median
time: 5 months). All participants were instructed to report
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specifically instructed to report conditions prior to diagnosis.
Based on questions on leisure-time physical activity (de-
scribed in detail previously [20]), participants were cate-
gorised into four levels: sedentary, low, moderate, and high
physical activity and further into low-risk (moderate and high
activity) and other (sedentary and low activity) lifestyle cate-
gory. Self-reported body-mass index (BMI) was calculated as
kg/m2; for cases, this information was highly correlated with
clinical measurements taken at diagnosis (r = 0.92). BMI < 25
was defined as the low-risk lifestyle category. Based on smok-
ing history, participants were categorized into current, for-
mer, and never smokers; the latter category was defined as
the low-risk lifestyle category.
Information on diet for ESTRID participants was obtained
through a validated [32] 132 item, semi-quantitative Food Fre-
quency Questionnaire (FFQ). Based on FFQ data, the nutrient
intake of each food item and total energy intake (kcal/day)
were estimated by multiplying frequency of consumption by
nutrient content according to the Swedish National Food
Agency Database considering age- and sex-specific portion
sizes [33]. We excluded participants with implausible total
energy intake, i.e. deviating > 2 standard deviations (SD) from
the loge-transformed mean intake of all participants (women,
<257.8 or > 6475.2 kcal/d; men, <401.1 or > 7537.7 kcal/d). Esti-
mation of a healthy diet was based on the ‘‘Life’s Simple 7”
dietary goals [3] including intake of vegetables and fruit
(low-risk cut-off: >400 g/day), fish (>2 servings/week), sugar-
sweetened beverages (<150 g/d, equals 64 kcal), whole-grain
(>48 g/d), and sodium (<1.5 g/d). We additionally included
consumption of processed red meat (<1 serving/d), because
it has recently been associated with increased risk of LADA
and type 2 diabetes [22]. Participants were classified into three
categories based on the healthy diet score, i.e. poor (0–2 diet-
ary components), intermediate (3–4 dietary components), and
healthy (5 dietary components achieved); the latter was
defined as the low-risk lifestyle category. Participants were
also asked to report how often during the previous year, they
consumed alcoholic beverages by indicating one of nine pre-
defined frequency categories, ranging from ‘never’ to ‘3
times/day’. Based on information about amount and fre-
quency, the intake of alcohol as g/day was estimated [24].
Since moderate alcohol intake, defined as 5–30 g/d [34] has
been shown to be associated with a reduced risk of LADA
[24,34] alcohol consumption > 5 g/d was defined as the low-
risk lifestyle category. Furthermore, FHD was assessed based
on information on diabetes in first-degree relatives. No infor-
mation on FHD was available for genetic controls.
The combined lifestyle variable was created based on
accomplishments of the low-risk category of the individual
lifestyle components, including moderate-to-high physical
activity, a healthy diet, BMI < 25, non-smoking, and moderate
alcohol consumption. The combined lifestyle was divided
into three categories, similar to previous classifications in
relation to type 2 diabetes [3]: poor lifestyle (1 low-risk com-
ponents), moderate lifestyle (2–3 low-risk components), and
healthy lifestyle (4 low-risk components). Due to missing
FFQ data for genetic controls, the combined lifestyle variable
for analyses stratified by HLA and TCF7L2 was based on
accomplishments of the low-risk categories of the individuallifestyle components physical activity, BMI, smoking, and
alcohol consumption.
2.4. Statistical analyses
Differences in normally distributed characteristics were
determined using two-sided Student’s t-test (presented as
means and SD) and Wilcoxon rank sum tests for non-
normally distributed characteristics (presented as median
and interquartile range, IQR). Differences in proportions were
determined using Chi-squared tests.
We used conditional logistic regression to calculate odds
ratios (ORs) with 95% confidence intervals (CIs). ORs for LADA
and type 2 diabetes were calculated for individual lifestyle
components (low-risk vs. other) as well as the combined life-
style variable (healthy, moderate vs. poor, and healthy vs.
moderate/poor). ESTRID controls were used in all analyses
except for stratifications by genetic risk, where genetic con-
trols were used. All models were adjusted for age, sex, educa-
tional level (primary school, upper secondary school, or
university) and FHD, unless stated otherwise. Analyses were
stratified by FHD (first degree relative, yes or no), HLA (high
or low/moderate risk), and TCF7L2 rs7903146 (TT/CT or CC).
Population-attributable risk percentage (PAR%) was calcu-
lated to estimate the proportion of cases in the population
that would have been prevented if all participants would have
adopted the healthy lifestyle. PAR% was calculated as p*(1–1/
OR), where p is prevalence (in %) of the individual (other) or
combined (poor) lifestyle factor among cases and OR is the
adjusted odds ratio.
In sensitivity analyses, the ORs of LADA and type 2 dia-
betes in relation to individual lifestyle factors were assessed
after additional adjustment for BMI. Furthermore, we re-run
the main analyses (Table 2) using the genetic controls to
assess their validity (Table S8). We also performed separate
analyses of LADA cases stratified by GADA levels (Table S4).
3. Results
3.1. Characteristics
LADA patients were younger, leaner, had lower insulin secre-
tion, less insulin resistance and were more likely to be treated
with insulin than type 2 diabetes patients (Table 1). The
genetic controls were younger and more likely to be female
than the ESTRID controls (Table S1); this was by matching
on birthyear and sex. Overall, a moderate lifestyle (2–3 low-
risk components) was achieved by 47.6% of participants and
a healthy lifestyle (4 low-risk components) by 6.1%. Those
with a moderate or healthy lifestyle were younger, less likely
to have FHD, had higher education, and were slightly more
likely of Swedish origin compared to those with a poor life-
style (Table S2).
3.2. Lifestyle and LADA
Of the low-risk components, BMI < 25 was associated with the
largest risk reduction for LADA (OR 0.54, 95% CI 0.43–0.66)
(Table 2). Furthermore, moderate-to-high physical activity
(OR 0.73, 95% CI 0.60–0.90) and moderate alcohol consump-
Table 1 – Characteristics of individuals.
Controls LADA Type 2 diabetes P
No. of individuals 2217 571 1962 –
Men (%) 47.6 52.9 60.3 0.0017
Age at diagnosis/inclusion (Years, mean +/ SD) 58.9+/13.7 59+/12.3 63.3+/10.4 <0.0001
BMI (kg/m2, mean +/ SD) 26+/4.2 28.5+/5.7 31.2+/5.4 <0.0001
Insulin treatment (%) – 39.1 5.6 <0.0001
GADA (IU/mL, median, IQR) – 250 (218.5) – –
C-peptide (nM, median, IQR) – 0.7 (0.7) 1.2 (0.6) <0.0001
HOMA-B (median, IQR) – 40.5 (53.9) 71.3 (51.1) <0.0001
HOMA-IR (median, IQR) – 2.8 (2.7) 3.6 (2.0) <0.0001
Family history of diabetes (%) 25.6 45.4 51.1 0.0175
Low level of education (primary school, %) 21.9 25.9 34.9 <0.0001
Country of birth (SE, %) 88.3 89.5 87.6 0.2128
P, p-value estimating the difference between individuals with Type 2 Diabetes and LADA. Differences between levels of education were
determined for the whole variable (not separated by category).
Table 2 – Odds ratios and PAR% for LADA and type 2 diabetes by individual and combined lifestyle factors.
Individuals per group LADA Type 2 diabetes
LADA T2D Control OR (95% CI) PAR% (95% CI) OR (95% CI) PAR% (95% CI)
Physical activity
Other 377 1462 1280 1 1 1 1
Low-risk 194 500 937 0.73 (0.60, 0.90) 17.6 (6.8, 26.3) 0.48 (0.41, 0.55) 39.0 (33.4, 43.9)
Diet
Other 506 1785 1921 1 1 1 1
Low-risk 65 177 296 0.89 (0.66, 1.20) 9.5 (17.9, 29.8) 0.75 (0.61, 0.94) 22.3 (5.5, 35.8)
BMI
Other 410 1815 1203 1 1 1 1
Low-risk 161 147 1014 0.54 (0.43, 0.66) 33.4 (24.4, 40.7) 0.12 (0.10, 0.15) 81.1 (79.1, 83.5)
Smoking
Other 313 1222 1100 1 1 1 1
Low-risk 258 740 1117 0.89 (0.73, 1.08) 6.1 (4.3, 14.6) 0.73 (0.63, 0.83) 17.0 (10.3, 22.8)
Alcohol
Other 273 1011 950 1 1 1 1
Low-risk 298 951 1267 0.75 (0.62, 0.92) 11.8 (3.8, 18.3) 0.60 (0.52, 0.69) 20.6 (15.9, 24.8)
Combined lifestyle
Poor 262 1215 727 1 1 1 1
Moderate 280 732 1246 0.66 (0.54, 0.81) 15.5 (8.8, 21.0) 0.37 (0.32, 0.43) 38.8 (35.2, 41.9)
Healthy 29 15 244 0.40 (0.26, 0.61) 27.6 (17.9, 33.9) 0.05 (0.03, 0.09) 58.7 (56.3, 60.1)
Combined lifestyle (dichotomised)
Poor/moderate 542 1947 1973 1 1 1 1
Healthy 29 15 244 0.51 (0.34, 0.77) 46.2 (21.8, 62.5) 0.09 (0.05, 0.15) 90.5 (84.2, 94.1)
T2D, Type 2 diabetes; OR, odds ratio; CI, confidence interval; PAR%, population attributable risk percentage. Model was adjusted for age, sex,
family history of diabetes and level of education. Combined lifestyle: Poor lifestyle, 0–1 low-risk component; Moderate lifestyle, 2–3 low-risk
components; Healthy lifestyle, 4 + low-risk components.
4 d i a b e t e s r e s e a r c h a n d c l i n i c a l p r a c t i c e 1 7 4 ( 2 0 2 1 ) 1 0 8 7 6 0tion (OR 0.75, 95% CI 0.62–0.92) were associated with a lower
risk of LADA, whereas the associations with non-smoking
and a healthy diet were weaker (Table 2).
Regarding the combination of individual lifestyle compo-
nents, a reduced risk of LADA was seen in individuals with
a moderate (2–3 low-risk components) lifestyle (OR 0.66,
95% CI 0.54–0.81), which was more pronounced in individu-
als adhering to the healthy (4 low-risk components) life-
style (OR 0.40, 95% CI 0.26–0.61) when compared to those
with a poor lifestyle (Table 2). A healthy lifestyle was asso-
ciated with a reduced LADA risk in both women and men
(Fig. 1, Table S3). Estimation of PAR% indicated that almost
half of all individuals with LADA (46.2%, 95% CI 21.8%-62.5%) could be ascribed to a lifestyle that did not conform
to the low-risk pattern (4 low-risk components) (Table 2).
When restricting the analysis to highly autoimmune LADA
cases (GADA  250 U/mL), both a moderate (OR 0.74, 95%
CI 0.57–0.97) and a healthy (OR 0.50, 95% CI 0.29–0.85) life-
style were associated with a reduced risk (Table S4). The
PAR% was estimated at 21.1% (95% CI 6.2–29.8) for a poor
vs. healthy lifestyle. These results were more pronounced
for less autoimmune LADA (GADA in the lowest tercile; <
67.46 U/mL); OR was 0.15, 95% CI 0.05–0.42) for a healthy
lifestyle and PAR% was 47.4 (95% CI 32.2–52.9) for healthy
vs. poor lifestyle (Table S4).
Fig. 1 – Odds ratios for LADA and type 2 diabetes by combined lifestyle components. Odds ratios (ORs) and 95% confidence
intervals (CIs) for incident LADA (left panel) and type 2 diabetes (right panel) are presented for non-stratified individuals
(whole cohort, upper panel), and individuals stratified by sex (middle panel), or by family history of diabetes (with (+) or
without (-) known history of diabetes in first-degree family, lower panel). ORs were adjusted for age, sex, and level of
education. Horizontal lines display ORs as indicated by square and 95% CIs. Poor lifestyle, 0–1 low-risk component; Moderate
lifestyle, 2–3 low-risk components; Healthy lifestyle, 4 + low-risk components.
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LADA was associated with FHD, and HLA and TCF7L2 risk
genotypes (Table S5). A healthy lifestyle was associated with
a reduced risk of LADA in those with (OR 0.46, 95% CI 0.22–
0.93) and without (OR 0.36, 95% CI 0.21–0.62) FHD (Fig. 1,
Table S3). Similarly, an inverse association was seen both in
carriers of high-risk (OR 0.32, 95% CI 0.11–0.94) and in those
with low/intermediate-risk (OR 0.28, 95% CI 0.08–0.93) HLA
genotypes (Table 3). Furthermore, those with moderate life-
style had a reduced risk of LADA irrespective of TCF7L2 geno-
type (Table 3).
3.3. Lifestyle and type 2 diabetes
All five individual, low-risk lifestyle components were inver-
sely associated with type 2 diabetes (Table 2), including
moderate-to-high physical activity, a healthy diet, BMI < 25,
non-smoking, and moderate alcohol consumption. The risk
was reduced in those with a moderate (OR 0.37, 95% CI 0.32–
0.43) and healthy lifestyle (OR 0.05, 95% CI 0.03–0.09); both
in men and women (Fig. 1, Table S3). Estimation of PAR% indi-
cated that 90.5% of type 2 diabetes cases (95% CI 84.2%-94.1%)
were attributable to a lifestyle that did not conform to the
low-risk pattern. The inverse associations between moderate
and healthy lifestyles and T2D were seen irrespective of FHD
(Fig. 1, Table S3) and genotypes of TCF7L2 (Table 3).
3.4. Clinical characteristics by lifestyle
LADA patients with a poor lifestyle had higher HOMA-B and
C-peptide level, and lower levels of GADA, but were more
insulin resistant (HOMA-IR) than those with moderate orhealthy lifestyle (Table S6). Similarly, in type 2 diabetes a poor
lifestyle was characterised by higher HOMA-B, C-peptide, and
HOMA-IR values than a moderate or healthy lifestyle
(Table S6).
3.5. Sensitivity analyses
When we adjusted analyses of the individual lifestyle compo-
nents for BMI, the association between physical activity and
LADA was attenuated, whereas the association with alcohol
consumption remained (Table S7). For type 2 diabetes, the
associations with physical activity, smoking, and alcohol con-
sumption remained after adjustment for BMI, but the associ-
ation with diet was eliminated (Table S7). Substituting the
ESTRID controls for the genetic controls yielded similar asso-
ciations between the individual lifestyle factors and LADA
and type 2 diabetes, respectively (Table 2, Table S8).
4. Discussion
In this large population-based study, adherence to a healthy
lifestyle, including moderate-to-high physical activity, a
healthy diet, BMI < 25, non-smoking, and moderate alcohol
consumption, was associated with a 60% reduction in the risk
of LADA. Furthermore, almost half of all patients were attri-
butable to a lifestyle that did not conform to the low-risk pat-
tern. These findings are in line with results based on the
Norwegian HUNT study [25]. In addition, we observed, for
the first time, that a healthy lifestyle was associated with a
reduced risk of LADA irrespective of sex, FHD, and high-risk
genotypes of HLA and TCF7L2. Notably, we found a markedly
larger risk reduction for adopting a healthy over a moderate
Table 3 – Odds ratios and PAR% for LADA and Type 2 Diabetes by combined lifestyle factors stratified by HLA and TCF7L2.
Individuals per group LADA Type 2 diabetes
LADA T2D Control OR (95% CI) PAR% (95% CI) OR (95% CI) PAR% (95% CI)
Whole cohort Combined lifestyle Poor 199 874 422 1 1 1 1
Moderate 178 392 1097 0.40 (0.29, 0.55) 30.6 (23.0, 36.2) 0.23 (0.18, 0.30) 52.9 (48.1, 56.4)
Healthy 13 5 115 0.31 (0.14, 0.67) 35.2 (16.8, 43.9) 0.03 (0.01, 0.08) 66.7 (63.3, 68.1)
(dichotomised) Poor/moderate 377 1266 1519 1 1 1 1
Healthy 13 5 115 0.55 (0.26, 1.16) 43.5 (15.5, 71.5) 0.05 (0.02, 0.18) 94.6 (81.7, 97.6)
HLA high risk Combined lifestyle Poor 119 278 133 1 1 1 1
Moderate 109 120 353 0.36 (0.22, 0.59) 32.1 (20.6, 39.2) 0.19 (0.12, 0.30) 56.6 (48.9, 61.5)
Healthy 9 0 41 0.32 (0.11, 0.94) 34.1 (3.0, 44.7) NA NA
(dichotomised) Poor/moderate 228 398 486 1 1 1 1
Healthy 9 0 41 0.61 (0.22, 1.71) 37.5 (68–3, 75.0) NA NA
HLA low/inter. risk Combined lifestyle Poor 80 596 289 1 1 1 1
Moderate 69 272 744 0.39 (0.24, 0.62) 31.9 (19.9, 39.7) 0.25 (0.18, 0.34) 51.2 (45.1, 56.0)
Healthy 4 5 74 0.28 (0.08, 0.93) 37.6 (3.7, 48.1) 0.03 (0.01, 0.11) 66.2 (60.8, 67.6)
(dichotomised) Poor/moderate 149 868 1033 1 1 1 1
Healthy 4 5 74 0.50 (0.15, 1.60) 48.7 (58.4, 82.8) 0.06 (0.02, 0.22) 93.5 (76.0, 95.4)
TCF7L2 (TT or TC) Combined lifestyle Poor 110 451 170 1 1 1 1
Moderate 90 214 509 0.36 (0.23, 0.57) 34.3 (23.1, 41.3) 0.23 (0.16, 0.34) 52.0 (44.6, 56.7)
Healthy 5 3 57 0.18 (0.05, 0.62) 44.0 (20.4, 51.0) 0.03 (0.01, 0.12) 65.5 (59.4, 66.8)
(dichotomised) Poor/moderate 200 665 679 1 1 1 1
Healthy 5 3 57 0.34 (0.10, 1.13) 64.4 (12.7, 87.8) 0.06 (0.01,0.26) 93.6 (72.2, 96.6)
TCF7L2 (CC) Combined lifestyle Poor 89 423 252 1 1 1 1
Moderate 88 178 588 0.43 (0.26, 0.70) 27.4 (14.4, 35.6) 0.21 (0.14, 0.30) 55.4 (49.1, 60.3)
Healthy 8 2 58 0.53 (0.19, 1.52) 22.6 (25.0, 39.0) 0.03 (0.01, 0.21) 68.0 (55.4, 69.4)
(dichotomised) Poor/moderate 177 601 840 1 1 1 1
Healthy 8 2 58 0.90 (0.33, 2.44) 9.6 (137.8, 64.1) 0.06 (0.01, 0.44) 93.7 (55.8, 98.7)
Cases and controls were stratified using three SNPs to identify high-risk and low/intermediate HLA genotypes (see Materials and Methods for details) and by TCF7L2-rs7903146 (TT/TC vs. CC).
Analyses were based on cases with genetic information (LADA: n = 390, 68.3% of sample; Type 2 diabetes: n = 1271, 64.8% of sample) and genetic controls (n = 1634). OR, odds ratio; CI, confidence
interval; PAR%, population attributable risk percentage. Models were adjusted for age, sex and birth year (matching variables in the genetic analyses), and level of education. Poor lifestyle, 0–1 low-
risk component; Moderate lifestyle, 2–3 low-risk components; Healthy lifestyle, 4 + low-risk components. The combined lifestyle variable was based on accomplishments of the low-risk category of
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risk reduction was more comparable between the moderate
and healthy lifestyle. The influence of lifestyle on type 2 dia-
betes risk was more pronounced; a 91% risk reduction was
seen in individuals with a healthy lifestyle, and 91% of all
patients could be attributed to an unhealthy lifestyle. These
findings are in accordance with a recent meta-analysis
wherein individuals with the healthiest lifestyle had a 75%
reduced risk of type 2 diabetes [7]. A moderate lifestyle was
also associated with a reduced risk of LADA and type 2 dia-
betes, suggesting that improving at least some lifestyle fac-
tors already reduces the risk of diabetes, whereas adhering
to a healthier lifestyle may decrease the risk further.
Our findings suggest that lifestyle modifications may sub-
stantially reduce the risk of LADA also in individuals with
genetic susceptibility. Similar findingswere seen in type 2 dia-
betes, confirming those of a previous study based on two
prospective cohorts [35]. Our findings further confirmed those
of the HUNT study, wherein 69% of individuals with LADA
were estimated to be preventable by adhering to a healthy
lifestyle [25]. The preventive potential was smaller in our
study, i.e. 46%, whichmay either reflect the heterogenous nat-
ure of LADA [11,36] or differences in the definitions of a
healthy lifestyle, because smoking and diet were not included
in the previous study. It should be noted that the present
study was based on more than three times as many LADA
cases as the previous [25].
Notably, all individual lifestyle components were associ-
ated with a reduced risk of type 2 diabetes, whereas only
moderate-to-high physical activity, BMI < 25, and moderate
alcohol consumption were significantly associated with
LADA. Among the low-risk components, BMI < 25 was associ-
ated with the largest risk reduction for both LADA and type 2
diabetes, in accordance with previous studies [4,25]. This
highlights the importance of maintaining a healthy weight
to reduce diabetes risk. In the present study, only 6.1% of
study participants adhered to a healthy lifestyle, illustrating
the tremendous potential for improvement. Notably, a poor
lifestyle was more common in individuals who were older,
had low education, FHD, and who were of non-Swedish ori-
gin, indicating that these groups may benefit most from pre-
ventive efforts.
The investigated lifestyle factors have primarily been
linked type 2 diabetes through effects on insulin resistance
[7]. In support hereof, we found that both in LADA and type
2 diabetes, a poor lifestyle was associated with higher
HOMA-IR. Considering that the primary defect of LADA is
insulin deficiency caused by autoimmunity [9], it is not sur-
prising that the risk reduction for both the combined and
individual lifestyle factors were less pronounced for LADA
than type 2 diabetes, where insulin resistance plays a key role
in pathogenesis. Moreover, a healthy lifestyle was associated
with a larger risk reduction for less autoimmune than for
more autoimmune LADA, in whom autoimmunity and subse-
quent insulin deficiency is likely to be the main driver of dis-
ease onset. We noted that LADA patients adhering to a
healthy lifestyle tended to have higher GADA levels than
those with a poor lifestyle, worse beta cell function (HOMA-
B), but less insulin resistance (HOMA-IR). One explanation
could be that people with an unhealthy lifestyle develop insu-lin resistance, which will increase the demand on the beta
cells; this could hypothetically unmask an underlying
autoimmune process at an earlier stage, i.e. when there is
more remaining beta cell function than in people with a
healthy lifestyle who are not as insulin resistant. The idea
that the degree of insulin resistance may determine at what
stage in the autoimmune process LADAwill become manifest
has been proposed previously by Naik et al [37].
The strengths of this study include the population-based
design and large number of incident LADA patients. In addi-
tion, detailed information on lifestyle and potential con-
founders were available, including a validated FFQ [32]. We
used a case-control design with incident cases, which is the
most efficient design for rare outcomes like LADA [26]. A lim-
itation is that information on lifestyle is collected at time of
diagnosis; recall bias is introduced if cases have modified
their lifestyle following diagnosis and report accordingly.
Cases may also overestimate how unhealthy their previous
lifestyle was, which would lead to overestimation of associa-
tions. The validity of the study design is supported by the fact
that our type 2 diabetes results were in strong agreement with
findings from previous prospective studies where lifestyle
information was obtained several years prior to diagnosis
[7]. Even though the specificity of the GADA assay was high,
misclassification of type 2 diabetes cases into the LADA group
could have contributed to an association between a healthy
lifestyle and LADA. On the other hand, there was an inverse
association between a healthy lifestyle and highly autoim-
mune LADA, where misclassification of type 2 diabetes cases
is unlikely. Some control individuals may have undiagnosed
diabetes at inclusion; this would lead to underestimation of
the associations. Another limitation is the use of external
controls for stratification analyses based on genetic risk.
Importantly, we observed the similar results when we
repeated the main analysis using the genetic controls
(Table S8), which supports their validity. The estimated poten-
tial for prevention is determined by our definition of low-risk
components and a healthy lifestyle, which was determined a
priori and similar to definitions used in previous type 2 dia-
betes studies [4,7,25,38]. We used the same definition for both
outcomes to allow for comparisons. In addition, we defined a
healthy diet based on the Life’s Simple 7 recommendations [3]
whereas other dietary factors may also play a role. We could
adjust for several potential confounders; still, there may be
residual confounding due to unmeasured or inaccurately
determined factors. PAR% should be interpreted cautiously,
because it was, by definition, based both on the assumption
of causality and absence of measurement errors and bias.
Finally, the study was conducted in Sweden, and adherence
to different lifestyle patterns may not be representative for
other populations. Still, previous studies from other countries
found similar proportions of participants adhering to low-risk
behaviours [3,7]. Incidence of autoimmune diabetes is rela-
tively high in Scandinavia and the results may not be general-
isable to low incidence regions. The prevalence of LADAvaries
across populations; this could reflect that the proportion car-
rying high-risk HLA genotypes varies [39]. In addition, preva-
lence of lifestyle risk factors, especially obesity, may
contribute to these differences. In general, research focusing
on the risk of LADA in relation to lifestyle factors is limited
8 d i a b e t e s r e s e a r c h a n d c l i n i c a l p r a c t i c e 1 7 4 ( 2 0 2 1 ) 1 0 8 7 6 0and primarily based on Scandinavian studies [17,21,36]. Con-
firmation of our findings in other populations is clearly
needed.
In conclusion,we find a reduced risk of LADAaswell as type
2 diabetes in peoplewith a healthy lifestyle, including BMI < 25,
no smoking, a healthy diet, moderate alcohol consumption,
and physical activity. Out of these components, maintaining
normal weight was associated with the largest risk reduction,
but the combined healthy lifestyle resulted in a lower risk for
LADA thanany lifestyle component alone. Intervention studies
have shown that it is possible to prevent type 2 diabetes
through lifestyle modification. Such studies are lacking in
LADA but clearly needed to elucidate whether the observed
associations are causal and the disease in part preventable.
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Nat Rev Endocrinol 2019;15:288–98. https://doi.org/10.1038/
s41574-019-0176-8.
[2] Aune D, Norat T, Leitzmann M, Tonstad S, Vatten LJ. Physical
activity and the risk of type 2 diabetes: A systematic review
and dose-response meta-analysis. Eur J Epidemiol
2015;30:529–42. https://doi.org/10.1007/s10654-015-0056-z.
[3] Fretts AM, Howard BV, McKnight B, Duncan GE, Beresford
SAA, Mete M, et al. Life’s simple 7 and incidence of diabetes
among American Indians: The strong heart family study.
Diabetes Care 2014;37:2240–5. https://doi.org/10.2337/dc13-
2267.
[4] Hu FB, Manson JE, Stampfer MJ, Colditz G, Liu S, Solomon CG,
et al. Diet, lifestyle, and the risk of type 2 diabetes mellitus in
women. N Engl J Med 2001;345:790–7. https://doi.org/10.1056/
NEJMoa010492.
[5] Pan A, Wang Y, Talaei M, Hu FB, Wu T. Relation of active,
passive, and quitting smoking with incident type 2 diabetes:
A systematic review and meta-analysis. Lancet Diabetes
Endocrinol 2015;3:958–67. https://doi.org/10.1016/S2213-8587
(15)00316-2.
[6] Knott C, Bell S, Britton A. Alcohol consumption and
the risk of type 2 diabetes: A systematic review and
Dose-Response Meta-analysis of more than 1.9 million
individuals from 38 observational studies. Diabetes Care
2015;38:1804–12.. https://doi.org/10.2337/dc15-0710.
[7] Zhang YYY, Pan X-F, Chen J, Xia L, Cao A, Zhang YYY, et al.
Combined lifestyle factors and risk of incident type 2
diabetes and prognosis among individuals with type 2
diabetes: a systematic review and meta-analysis of
prospective cohort studies. Diabetologia 2019. https://doi.org/
10.1007/s00125-019-04985-9.
[8] Uusitupa M, Khan TA, Viguiliouk E, Kahleova H, Rivellese AA,
Hermansen K, et al. Prevention of Type 2 Diabetes by Lifestyle
Changes: A Systematic Review and Meta-Analysis. Nutrients
2019;11:2611. https://doi.org/10.3390/nu11112611.
[9] Carlsson S. Etiology and Pathogenesis of Latent Autoimmune
Diabetes in Adults (LADA) Compared to Type 2 Diabetes.
Front Physiol 2019;10.. https://doi.org/10.3389/
fphys.2019.00320.
[10] Tuomi T, Santoro N, Caprio S, Cai M, Weng J, Groop L. The
many faces of diabetes: A disease with increasing
heterogeneity. Lancet 2014;383:1084–94. https://doi.org/
10.1016/S0140-6736(13)62219-9.
[11] Østergaard JA, Laugesen E, Leslie RD. Should There be
Concern About Autoimmune Diabetes in Adults? Current
Evidence and Controversies. Curr Diab Rep 2016;16:82.
https://doi.org/10.1007/s11892-016-0780-0.
[12] Hjort R, Alfredsson L, Andersson T, Carlsson PO, Grill V, Groop
L, et al. Family history of type 1 and type 2 diabetes and risk
of latent autoimmune diabetes in adults (LADA). Diabetes
Metab 2017;43:536–42. https://doi.org/10.1016/
j.diabet.2017.05.010.
d i a b e t e s r e s e a r c h a n d c l i n i c a l p r a c t i c e 1 7 4 ( 2 0 2 1 ) 1 0 8 7 6 0 9[13] Groop L, Tuomi T, Rowley M, Zimmet P, Mackay IR. Latent
autoimmune diabetes in adults (LADA) - More than a name.
Diabetologia 2006;49:1996–8. https://doi.org/10.1007/s00125-
006-0345-x.
[14] Cousminer DL, Ahlqvist E, Mishra R, Andersen MK, Chesi A,
Hawa MI, et al. First genome-wide association study of latent
autoimmune diabetes in adults reveals novel insights linking
immune and metabolic diabetes. Diabetes Care
2018;41:2396–403. https://doi.org/10.2337/dc18-1032.
[15] Andersen MK, Sterner M, Forsén T, Käräjämäki A, Rolandsson
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